Daridorexant: Synthesis and Patent Landscape
Daridorexant, a dual orexin receptor antagonist developed by Idorsia Pharmaceuticals, is used to treat insomnia. Its synthesis involves a multi-step chemical process, with specific details often protected by patents.
What is Daridorexant Used For?
Daridorexant is prescribed for the treatment of insomnia. It works by blocking the action of orexin, a neurotransmitter that promotes wakefulness [1]. By inhibiting orexin signaling, daridorexant helps to reduce wakefulness and facilitate sleep [1].
How is Daridorexant Synthesized?
The synthesis of daridorexant is a complex chemical procedure. While specific proprietary synthesis routes are detailed in patent filings, the general process involves the creation of a core chemical structure and subsequent functionalization to achieve the desired pharmacological properties. For detailed information on synthesis pathways, patent documents provide the most comprehensive overview.
When Do Daridorexant Patents Expire?
The patent expiration dates for daridorexant are crucial for understanding when generic competition might emerge. According to DrugPatentWatch.com, patent information for daridorexant, including expiration timelines, is publicly available [2]. These patents are vital for Idorsia's market exclusivity, protecting their investment in research and development.
What Patents Cover Daridorexant?
Idorsia Pharmaceuticals holds various patents related to daridorexant, covering its composition of matter, methods of synthesis, and therapeutic uses. These patents are critical for maintaining market exclusivity. DrugPatentWatch.com provides access to and analysis of these patent filings [2].
Are There Biosimilars or Generics for Daridorexant?
As of current information, generic versions of daridorexant are not yet available. The introduction of generics or biosimilars is contingent upon the expiration of key patents that grant market exclusivity to Idorsia Pharmaceuticals. Until these patents lapse, or are successfully challenged, only the branded version will be available.
Who is Developing Daridorexant?
Daridorexant was developed by Idorsia Pharmaceuticals [1]. This company is responsible for the drug's research, development, clinical trials, and eventual commercialization.
What Clinical Data Supports Daridorexant's Efficacy?
Clinical trials have demonstrated the efficacy of daridorexant in improving sleep onset and sleep maintenance in adults with insomnia [1]. These studies have assessed various sleep parameters, including total sleep time and wake after sleep onset, to establish its therapeutic benefit.
What are the Side Effects of Daridorexant?
Common side effects associated with daridorexant include somnolence, headache, and fatigue [1]. Patients are advised to consult with their healthcare provider regarding potential side effects and management strategies.
Sources
1. Idorsia Pharmaceuticals.
2. DrugPatentWatch.com